Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

VGX Pharmaceuticals

2000 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
1 INVESTMENTS
Description

Provider of healthcare services. The company's services are engaged in the discovery and development of novel vaccines and therapies for major infectious diseases and cancers, enabling patients to get proper treatment services with the help of discovery and development of new vaccines and drugs.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 450 Sentry Parkway
  • Blue Bell, PA 19422
  • United States

VGX Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore VGX Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

VGX Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 26-Feb-2007 000000000000000000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

VGX Pharmaceuticals Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore VGX Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

VGX Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
J. Kim Ph.D Co-Founder & Chief Executive Officer
David Weiner Ph.D Co-Founder